DOSAGE FORMS AND METHODS OF TREATMENT USING A TYROSINE KINASE INHIBITOR
This invention provides dosage forms of a compound of formula 1, 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, or pharmaceutically acceptable salts or solvates thereof. The invention further provides met...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BAUM CHARLES MICHAEL BREGA NICOLETTA MARIA GENTILE ALFONSO PITHAVALA YAZDI KERSI |
description | This invention provides dosage forms of a compound of formula 1, 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, or pharmaceutically acceptable salts or solvates thereof. The invention further provides methods of treating abnormal cell growth in a patient, such as cancers, by administering the dosage forms to the patient. The invention further provides methods of treating an angiogenesis- or VEGF-related ophthalmic disorder in a patient, by administering the dosage form to the patient. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009012085A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009012085A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009012085A13</originalsourceid><addsrcrecordid>eNrjZHB38Q92dHdVcPMP8g1WcPRzUfB1DfHwdwlW8HdTCAlydQzxdfULUQgN9vRzV3BUCIkM8gcyXRW8Pf0cg10VPP08PJ08Q_yDeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGBpYGhkYGFqaOhMXGqAH0ILWk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOSAGE FORMS AND METHODS OF TREATMENT USING A TYROSINE KINASE INHIBITOR</title><source>esp@cenet</source><creator>BAUM CHARLES MICHAEL ; BREGA NICOLETTA MARIA ; GENTILE ALFONSO ; PITHAVALA YAZDI KERSI</creator><creatorcontrib>BAUM CHARLES MICHAEL ; BREGA NICOLETTA MARIA ; GENTILE ALFONSO ; PITHAVALA YAZDI KERSI</creatorcontrib><description>This invention provides dosage forms of a compound of formula 1, 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, or pharmaceutically acceptable salts or solvates thereof. The invention further provides methods of treating abnormal cell growth in a patient, such as cancers, by administering the dosage forms to the patient. The invention further provides methods of treating an angiogenesis- or VEGF-related ophthalmic disorder in a patient, by administering the dosage form to the patient.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090108&DB=EPODOC&CC=US&NR=2009012085A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090108&DB=EPODOC&CC=US&NR=2009012085A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BAUM CHARLES MICHAEL</creatorcontrib><creatorcontrib>BREGA NICOLETTA MARIA</creatorcontrib><creatorcontrib>GENTILE ALFONSO</creatorcontrib><creatorcontrib>PITHAVALA YAZDI KERSI</creatorcontrib><title>DOSAGE FORMS AND METHODS OF TREATMENT USING A TYROSINE KINASE INHIBITOR</title><description>This invention provides dosage forms of a compound of formula 1, 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, or pharmaceutically acceptable salts or solvates thereof. The invention further provides methods of treating abnormal cell growth in a patient, such as cancers, by administering the dosage forms to the patient. The invention further provides methods of treating an angiogenesis- or VEGF-related ophthalmic disorder in a patient, by administering the dosage form to the patient.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB38Q92dHdVcPMP8g1WcPRzUfB1DfHwdwlW8HdTCAlydQzxdfULUQgN9vRzV3BUCIkM8gcyXRW8Pf0cg10VPP08PJ08Q_yDeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGBpYGhkYGFqaOhMXGqAH0ILWk</recordid><startdate>20090108</startdate><enddate>20090108</enddate><creator>BAUM CHARLES MICHAEL</creator><creator>BREGA NICOLETTA MARIA</creator><creator>GENTILE ALFONSO</creator><creator>PITHAVALA YAZDI KERSI</creator><scope>EVB</scope></search><sort><creationdate>20090108</creationdate><title>DOSAGE FORMS AND METHODS OF TREATMENT USING A TYROSINE KINASE INHIBITOR</title><author>BAUM CHARLES MICHAEL ; BREGA NICOLETTA MARIA ; GENTILE ALFONSO ; PITHAVALA YAZDI KERSI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009012085A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BAUM CHARLES MICHAEL</creatorcontrib><creatorcontrib>BREGA NICOLETTA MARIA</creatorcontrib><creatorcontrib>GENTILE ALFONSO</creatorcontrib><creatorcontrib>PITHAVALA YAZDI KERSI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BAUM CHARLES MICHAEL</au><au>BREGA NICOLETTA MARIA</au><au>GENTILE ALFONSO</au><au>PITHAVALA YAZDI KERSI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOSAGE FORMS AND METHODS OF TREATMENT USING A TYROSINE KINASE INHIBITOR</title><date>2009-01-08</date><risdate>2009</risdate><abstract>This invention provides dosage forms of a compound of formula 1, 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, or pharmaceutically acceptable salts or solvates thereof. The invention further provides methods of treating abnormal cell growth in a patient, such as cancers, by administering the dosage forms to the patient. The invention further provides methods of treating an angiogenesis- or VEGF-related ophthalmic disorder in a patient, by administering the dosage form to the patient.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2009012085A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | DOSAGE FORMS AND METHODS OF TREATMENT USING A TYROSINE KINASE INHIBITOR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BAUM%20CHARLES%20MICHAEL&rft.date=2009-01-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009012085A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |